Press Releases

Sabinsa, the pioneer of ingredients conceived by modern science drawn from traditional Ayurvedic knowledge, has obtained Novel Food approval from the European Food Safety Authority (EFSA) for the company’s patented Curcumin C3 Reduct®, which contains the curcuminoid metabolites Tetrahydrocurcuminoids (THCs).

 

Sabinsa’s flagship combination product, Curcumin C3 Complex^® with BioPerine^® (525mg/2.5 mg twice a day, 14 days), was used as adjuvant therapy for COVID-19 in a double-blind.

 

Sabinsa’s Curcumin C3 Complex^®, the #1 clinically studied curcumin brand on the market, is the subject of a recently published study on its effect, combined with BioPerine^®, on serum cytokine concentrations.

 

Sabinsa’s Curcumin C3 Complex^®, the #1 researched curcumin ingredient on the market, was used in a new published study on Non-Alcoholic Fatty Liver Disease (NAFLD), the most common chronic liver condition for which no approved pharmaceutical treatments exist.

 

The body of research supporting efficacy of Sabinsa’s branded ingredients continues to grow with a recent clinical paper reporting on the use of the company’s Curcumin C3 Complex^® and BioPerine^®, and taurine on hepatocellular carcinoma (HCC) patients:

 

Sabinsa’s Curcumin C3 Complex^® in combination with BioPerine^® (CBP) has an inhibitory effect on malignant mesothelioma cells, according to an in vitro and in vivo study published in Journal of Experimental and Clinical Cancer Research.

 

Sabinsa has been promoting the combination of its Curcumin C3 Complex and BioPerine for more than two decades based upon research showing the synergy between the company’s proprietary curcumin and piperine ingredients.

 

Resveratrol has been shown to possess a range of health-promoting properties in animal trials, including increasing mitochondrial capacity in exercise; however, results have been inconsistent in human trials. Piperine enhances the bioavailability of some ingredients. Together, they were studied for the potential to increase the effectiveness of skeletal muscle mitochondrial performance during low-intensity exercise training in a clinical study.

 

Metabolic syndrome places people at a higher risk for health complications, and since it involves simultaneous occurrence of several risk factors, it can be difficult to manage. Natural alternatives that support general well-being could be beneficial.

 

As probiotics have become increasingly popular aiding gastrointestinal (GI) issues, one clinical trial explored the potential of a probiotic strain in helping support healthy bowel movement.

 

With research suggesting enzymes offer anti-inflammatory effects, one clinical study examined the potential of a multi-enzyme complex to help manage delayed onset muscle soreness (DOMS) after unaccustomed exercise.

 

Sabinsa has just published a book on the company’s patented black pepper extract, BioPerine^®, which is widely used to enhance the bioavailability of other nutrients as well as for its thermo-nutrient properties. The book, “BioPerine^®  – Nature’s Own Super Nutrient,” was written by several of the company’s scientists, including Dr. Muhammad Majeed, founder of Sabinsa Corporation. 

 

A recent human clinical study by the University of Georgia Department of Kinesiology in Athens, Georgia found that Resveratrol fortified with Sabinsa’s BioPerine^® increases mitochondrial function. The study, Influence of exercise training with resveratrol supplementation on skeletal muscle mitochondrial capacity by Kristine R. Polley, Nathan Jenkins, Patrick O’Connor, and Kevin McCully, was published in Applied Physiology, Nutrition and Metabolism (41: 26–32 (2016) dx.doi.org/10.1139/apnm-2015-0370).

 

Another significant study on the combination of Curcumin C3 Complex^® and BioPerine^®, Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial, by researchers at University of Medical Sciences, Mashhad, Iran, has been published in Complementary Therapies in Medicine 2014; 22(5): 851-857.  

 

In a significant study on the Curcumin C3 Complex^® and BioPerine^® combination, researchers at University of Medical Sciences, Mashhad, Iran observed considerable benefits of this combination in the management of knee osteoarthritis. The study was published in Phytotherapy Research and entitled Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Trial. 

 

Dr. N. Kalyanam, President of Sabinsa’s New Jersey R&D, will give a presentation on BioPerine^® on June 19, 2012 as part of the SupplySide Science Tour held at the Hyatt Regency Irvine, Irvine, California.

 

TA study published in the August Volume of Molecular Nutrition & Food Research (Special Issue: Resveratrol – Current Status and Outlook) entitled Enhancing the bioavailability of resveratrol by combining it with piperine, found that the absorption of resveratrol was significantly increased when combined with piperine (black pepper extract) in lab mice.

 

Sabinsa Corporation has been granted its fourth patent on *Bioperine^®, a proprietary ingredient developed by the company which has been clinically shown to increase the bioavailibility of nutritional supplements, thus making them more effective. Additionally, the Bioperine trademark has been officially accepted and recognized as a trademark in Europe.

 

Sabinsa Corporation received Generally Recognized As Safe (GRAS) status for its popular patented bioavailability enhancement ingredient BioPerine^® – black pepper extract, after a comprehensive review of safety and toxicology data by an independent panel of scientists with international repute assembled by Soni & Associates, Inc.

 

Sabinsa Corporation today announced that it has secured a patent in Canada for its branded ingredient Bioperine^®, a standardized piperine composition derived from black pepper extract. Patent #2,247,467 protects the use of piperine as a bioavailability enhancer and affirms that Bioperine is the only black pepper extract that can legally be used in nutritional supplements for the purpose of enhancing the bioavailability of nutrients in Canada.

 

Sabinsa Corporation today announced that it has secured a patent in Japan for its branded ingredient Bioperine^®, a standardized piperine composition derived from black pepper extract. Patent #3953513, Sabinsa’s first in Japan, protects the use of piperine as a bioavailability enhancer and affirms that Bioperine is the only black pepper extract that can legally be used in nutritional supplements for the purpose of enhancing the bioavailability of nutrients.

 

For the first time, a foreign company engaging in alleged Intellectual Property (IP) theft at a dietary supplements industry trade show has been stopped in its tracks.

 

Sabinsa Corporation has been granted a third patent on Bioperine^®, a proprietary ingredient developed by the company which has been clinically shown to increase the bioavailibility of nutritional supplements, thus making them more effective.

 

Sabinsa Corporation’s founder Muhammed Majeed, PhD and Vice President of Scientific and Medical Affairs, Vladimir Badmaev, MD, PhD., have authored an article to appear in a peer-reviewed joumal, Nutrition Research.

 

Dr. Muhammed Majeed, founder, President and CEO of the Sabinsa Corporation, Piscataway, New Jersey, received the President’s Award for Quality and Innovation from Dr. Shankar Dayal Sharma, President of India on October 11, 1995. Sabinsa’s research and manufacturing facility located in India, was named company of the year.

 

Sabinsa Corporation has been granted a patent on Bioperine^®, a new ingredient developed by the company which has been shown to increase the bioavailability of supplements.